Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UCTT
726
Ultra Clean Holdings
UCTT
$3.12B
| $10.1M | 0.01% |
282,023
-508
| -0.2% | -$18.8K |
|
727
HEICO Corp
HEI
$49.6B
| $10.1M | 0.01% |
42,336
-1,637
| -4% | -$424K |
|
|
CHX
728
DELISTED
ChampionX
CHX
| $10.1M | 0.01% |
370,166
+80,566
| +28% | +$2.4M |
|
729
Constellation Energy
CEG
$92.1B
| $10M | 0.01% |
44,682
-583
| -1% | -$145K |
|
|
CPRX
730
DELISTED
Catalyst Pharmaceutical
CPRX
| $9.94M | 0.01% |
476,023
+115,832
| +32% | +$2.49M |
|
731
West Fraser Timber
WFG
$5.21B
| $9.92M | 0.01% |
115,901
+41,087
| +55% | +$3.85M |
|
732
MarketAxess Holdings
MKTX
$4.47B
| $9.88M | 0.01% |
43,710
+40,501
| +1,262% | +$10.7M |
|
733
Bentley Systems
BSY
$11.2B
| $9.8M | 0.01% |
209,917
+30,123
| +17% | +$1.47M |
|
734
Johnson Controls International
JCI
$85.1B
| $9.77M | 0.01% |
123,703
-663
| -0.5% | -$53.2K |
|
735
Interactive Brokers
IBKR
$38.4B
| $9.68M | ﹤0.01% |
219,260
-61,712
| -22% | -$2.6M |
|
736
Regeneron Pharmaceuticals
REGN
$72.9B
| $9.6M | ﹤0.01% |
13,473
-84,661
| -86% | -$71M |
|
737
Nucor
NUE
$58.3B
| $9.55M | ﹤0.01% |
81,801
+47,403
| +138% | +$6.82M |
|
|
BNY
738
Bank of New York Mellon
BNY
$103B
| $9.55M | ﹤0.01% |
124,273
+22,179
| +22% | +$1.71M |
|
739
Colgate-Palmolive
CL
$74.8B
| $9.55M | ﹤0.01% |
104,991
-37,455
| -26% | -$3.57M |
|
740
TransDigm Group
TDG
$70.7B
| $9.41M | ﹤0.01% |
7,431
+229
| +3% | +$302K |
|
741
Yeti Holdings
YETI
$3.87B
| $9.25M | ﹤0.01% |
240,275
+161,467
| +205% | +$6.42M |
|
742
Toronto Dominion Bank
TD
$193B
| $9.18M | ﹤0.01% |
172,347
-11,500
| -6% | -$645K |
|
743
Illinois Tool Works
ITW
$84.1B
| $9.17M | ﹤0.01% |
36,142
-1,185
| -3% | -$314K |
|
744
Addus HomeCare
ADUS
$2.22B
| $9.15M | ﹤0.01% |
73,005
+17,641
| +32% | +$2.23M |
|
745
CrowdStrike
CRWD
$183B
| $9.12M | ﹤0.01% |
106,596
-4,452
| -4% | -$370K |
|
746
Blue Owl Capital
OWL
$6.45B
| $9.09M | ﹤0.01% |
390,592
+32,700
| +9% | +$748K |
|
747
Hamilton Lane
HLNE
$3.88B
| $9.07M | ﹤0.01% |
61,252
+11,959
| +24% | +$2.13M |
|
748
Vale
VALE
$62.3B
| $9.02M | ﹤0.01% |
+1,016,761
| New | +$10.3M |
|
|
CADE
749
DELISTED
Cadence Bank
CADE
| $8.99M | ﹤0.01% |
261,017
-221,123
| -46% | -$7.78M |
|
750
Ecolab
ECL
$79.8B
| $8.97M | ﹤0.01% |
38,277
-16,371
| -30% | -$4.07M |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.